Showing results (1001-1010 of 6,881) with videos related to

Sort By:
Pageof 689
Leukemia Research|November 6, 2017
Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessmentVictoria R Nachar, Anthony J Perissinotti, Gianni B Scappaticci, et al.
Leukemia Research|November 6, 2017
DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemiaHakan Ozdogan, Bala Gur Dedeoglu, Yasemin Oztemur Islakoglu, et al.
Leukemia Research|January 19, 2018
Expression of autophagy related genes in chronic lymphocytic leukemia is associated with disease courseYi-Lin Kong, Ying Huang, Jia-Zhu Wu, et al.
Leukemia Research|January 22, 2018
CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopeniaJinjin Huang, Zhiqiong Wang, Lifang Huang, et al.
Leukemia Research|February 7, 2018
Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromesPei Liu, Huijuan Jiang, Mengting Che, et al.
Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Leukemia Research|February 7, 2018
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDSLouise de Swart, Alex Smith, Detlef Haase, et al.
Leukemia Research|February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent dosesPatrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.
Leukemia Research|February 7, 2018
8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasmsPrajwal C Boddu, Sa A Wang, Naveen Pemmaraju, et al.
Leukemia Research|February 7, 2018
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRAArdeshir Ghavamzadeh, Mahdi Jalili, Sharbanoo Rostami, et al.
Pageof 689